Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations. - Wikidata - wikimedia - TriplyDB

Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.

Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.

http://www.wikidata.org/entity/Q37859395

about

Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors Anti-human immunodeficiency virus type 1 activity of novel 6-substituted 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives.Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque HIV-1 and HIV-2 reverse transcriptases: different mechanisms of resistance to nucleoside reverse transcriptase inhibitors.Prevalence of Drug Resistance and Associated Mutations in a Population of HIV-1(+) Puerto Ricans: 2006-2010.Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivo.Unfolding the HIV-1 reverse transcriptase RNase H domain--how to lose a molecular tug-of-war.Follow-up on long-term antiretroviral therapy for cats infected with feline immunodeficiency virus.Role of phenotypic investigation in the era of routine genotypic HIV-1 drug resistance testing

P2860

Q26764925-D514872A-FDBF-4095-9123-F7024B20EF14 Q34145448-6048A56E-03CD-4CB5-81F0-31279B61F2D2 Q34475019-1C34B345-D83E-4220-80C6-6A1FB9E7B94D Q35943486-66C677CE-B3FD-437C-962D-B45824574495 Q35944787-4FE3693E-1BF0-4C3C-978F-9DDCBCBE934D Q36172536-930C9498-A2F5-4E0A-95B3-F790A16AB523 Q36627970-E998E32A-E9B0-40C5-A51B-4A0490FB7B45 Q41098894-78405541-564E-4FFA-8903-3EFC5A213C31 Q56792140-A0FCB413-865C-46D1-9EC0-B7D75EEE7E2E

P2860

Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.

http://www.wikidata.org/entity/Q37859395

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.

@en

Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.

@nl

type

label

Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.

@en

Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.

@nl

prefLabel

Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.

@en

Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.

@nl

P1433

Q37859395-31D1DC3A-8660-4635-97E3-78B2FF64D615

P1476

Q37859395-299E6D11-ED0C-46A8-8774-AD7FC469433C

P2093

Q37859395-DD103150-33A1-4F24-BCF0-0E7A4A93E0EB

Q37859395-F5A9E07C-3438-443A-A3B3-600CFCE6F3E5

P2860

Q37859395-03F96221-652A-4075-8C57-4B4D0C081344

Q37859395-042BF6F9-0FC3-4FDB-A18A-52466EEA9424

Q37859395-04AC04CF-A8D4-4E26-8DDF-8983E67054E9

Q37859395-0843B943-6163-4D67-BD75-CCB524A7926B

Q37859395-08D609B0-7126-4EBE-9705-EC67F2FC17A2

Q37859395-16C32CB0-289B-44E2-8AFF-9BAD59AB9FE5

Q37859395-1785A5A1-6168-4E6A-8FAF-DCEFB36D7A09

Q37859395-17CBDA2F-051F-43C2-A552-3AC9601510EC

Q37859395-18107D58-4118-4054-B0E1-DD16322FDD46

Q37859395-19F4138D-595E-4C03-B81B-E3749B3FF550

P304

Q37859395-CE7E7602-B227-4190-95AA-F85C4E100930

P31

Q37859395-ED5E9742-263F-4B6B-B036-9F7DA0B03A64

P356

Q37859395-BAEF9F8A-69B2-40C5-9465-6F39BC42FCF3

P433

Q37859395-A712269D-8D91-4FB8-9E62-52115D9652C9

P478

Q37859395-9E19D464-02F6-4AD8-9F37-A5C6321362B7

P577

Q37859395-093832BB-D2CF-438B-829E-9701622A235F

P698

Q37859395-65600F03-3AE9-4E83-BF75-05FEBCAD95AE

P921

Q37859395-7B03AFF6-2C20-4447-80D0-8D170EF4DEC4

P356

P1433

Future Microbiology

P1476

Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.

@en

P2093

Shiro Ibe

http://www.w3.org/2001/XMLSchema#string

Wataru Sugiura

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)

A new human immunodeficiency virus derived from gorillas

Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase

Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors.

Structural basis of HIV-1 resistance to AZT by excision

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids

Why do HIV-1 and HIV-2 use different pathways to develop AZT resistance?

P304

295-315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FMB.11.7

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21449841

http://www.w3.org/2001/XMLSchema#string

P921